Evidence map›Paper›PMID 37253387›Full record

Trial reportEndoscopy2023

Endoscopic vacuum therapy for anastomotic leakage after upper gastrointestinal surgery.

Lisanne M D Pattynama, Roos E Pouw, Mark I van Berge Henegouwen, Freek Daams, Suzanne S Gisbertz, Jacques J G H M Bergman, Wietse J Eshuis

Erratum issuedAbstract readClinical Trial
In one paragraph

Trial report in Endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Endoscopic vacuum therapy in the upper gastrointestinal tract.Frontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Lisanne M D PattynamaDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-4136-4778
Roos E PouwCancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Mark I van Berge HenegouwenDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Freek DaamsCancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Suzanne S GisbertzDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Jacques J G H M BergmanDepartment of Gastroenterology and Hepatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Wietse J EshuisDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, endoscopic vacuum therapy (EVT) was introduced as treatment for anastomotic leakage after upper gastrointestinal (GI) surgery. The aim of this study was to describe the initial experience with EVT for anastomotic leakage after upper GI surgery in a tertiary referral center.

methodsPatients treated with EVT for anastomotic leakage after upper GI surgery were included retrospectively (January 2018-June 2021) and prospectively (June 2021-October 2021). The primary end point was the EVT success rate. Secondary end points included mortality and adverse events.

results38 patients were included (31 men; mean age 66 years): 27 had undergone an esophagectomy with gastric conduit reconstruction and 11 a total gastrectomy with esophagojejunal anastomosis. EVT was successful in 28 patients (74 %, 95 %CI 57 %-87 %). In 10 patients, EVT failed: deceased owing to radiation pneumonitis (n = 1), EVT-associated complications (n = 2), and defect closure not achieved (n = 7). Mean duration of successful EVT was 33 days, with a median of six EVT-related endoscopies. Median hospital stay was 45 days.

conclusionThis initial experience with EVT for anastomotic leakage after upper GI surgery demonstrated a success rate of 74 %. EVT is a promising therapy that could prevent further major surgery. More experience with the technique and its indications will likely improve success rates in the future.

Indexed as

Anastomotic LeakNegative-Pressure Wound TherapyAgedEndoscopyEsophagectomyGastrectomyHumansMaleRetrospective Studies

Identifiers

PMID37253387
PMCPMC10602657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.